Journal of Immunotherapy and Precision Oncology

Skip Nav Destination

Current Issue

Volume 8,

Issue 1

February 2025

View This Issue

ISSN: 2666-2345

eISSN: 2590-017X

Indexed by: Web of Science (ESCI), PMC, Scopus, DOAJ, Crossref

About this Journal

JIPO publishes high-quality manuscripts that appeal to a broad readership of healthcare professionals and scientists, especially those with an interest in oncology and immunology. JIPO is indexed by Web of Science (ESCI), PubMed Central (PMC), Scopus, Directory of Open Access Journals (DOAJ), and Crossref.

Browse Journal
Submit an Article
Subscribe

Featured Content

RESEARCH ARTICLE | August 19 2024

Assessment of Distinct Gut Microbiome Signatures in a Diverse Cohort of Patients Undergoing Definitive Treatment for Rectal Cancer

RESEARCH ARTICLE | August 19 2024

MC-Keyboard: A Practical Phase I Trial Design for Targeted Therapies and Immunotherapies Integrating Multiple-Grade Toxicities

REVIEW ARTICLE | February 05 2024

B7-H3 Inhibitors in Oncology Clinical Trials: A Review

Latest
Most Read

Selinexor (KPT-330) in Combination with Immune Checkpoint Inhibition in Uveal Melanoma: A Phase 1B Trial

Mohamed A. Gouda, Abdulrazzak Zarifa, Yali Yang, Bettzy Stephen, Serdar A. Gurses, Ashabari Sprenger, Yanyan Tian, Mohamed H. Derbala, Isabella Glitza Oliva, Funda Meric-Bernstam, Sapna P. Patel

Safety and Efficacy of Toripalimab in Patients with Cholangiocarcinoma: An Open-Label, Phase 1 Study

Aung Naing, Amit Mahipal, Milind Javle, Judy Wang, Todd M. Bauer, David L. Bajor, Anthony D. Elias, Anthony Shields, Elizabeth Davis, Sant Chawla, Howard Safran, John D. Powderly, Gina D’Amato, Christian F. Meyer, Xiongwen Tang, Sheng Yao, Patricia Keegan

Expert Clinical Management of Inflammatory Immune-Related Arthritis in Patients with Cancer Receiving Immune Checkpoint Inhibitors

Sebastian Bruera, Mar Riveiro-Barciela, Alexa Meara, Maria E. Suarez-Almazor

Usefulness of Comprehensive Genomic Profiling in Clinical Decision-Making in Oncology: A Systematic Review

Sewanti Limaye, Jayesh Deshmukh, Nitesh Rohatagi, Kumar Prabhash, Amit Rauthan, Shambhavi Singh, Arun Kumar

Cyclin Dependent Kinase 2 (CDK2) Inhibitors in Oncology Clinical Trials: A Review

Isabelle House, Mari Valore-Caplan, Elijah Maris, Gerald S. Falchook